Antihyperglycemic Medications for Cardiovascular Disease Risk ReductionByJennifer D. Goldman, PharmD, RPh, CDE, BC-ADM, FCCPAugust 23rd 2018
Economic Implications With Newer Agents to Reduce Cardiovascular Risk in DiabetesByCarrie McAdam-Marx, MSCI, PhD, RPhAugust 23rd 2018
The Burden of Cardiovascular Disease in Patients with DiabetesByBrooke Hudspeth, PharmD, CDEAugust 23rd 2018
